9-134817127-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000093.5(COL5A1):​c.4176+48A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.419 in 1,550,680 control chromosomes in the GnomAD database, including 138,602 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 17322 hom., cov: 33)
Exomes 𝑓: 0.41 ( 121280 hom. )

Consequence

COL5A1
NM_000093.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.27

Publications

7 publications found
Variant links:
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • arterial disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 9-134817127-A-G is Benign according to our data. Variant chr9-134817127-A-G is described in ClinVar as [Benign]. Clinvar id is 255086.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.616 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A1NM_000093.5 linkc.4176+48A>G intron_variant Intron 53 of 65 ENST00000371817.8 NP_000084.3 P20908-1A0A024R8E5B2ZZ86Q59EE7
COL5A1NM_001278074.1 linkc.4176+48A>G intron_variant Intron 53 of 65 NP_001265003.1 B2ZZ86Q59EE7
COL5A1XM_017014266.3 linkc.4176+48A>G intron_variant Intron 53 of 64 XP_016869755.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A1ENST00000371817.8 linkc.4176+48A>G intron_variant Intron 53 of 65 1 NM_000093.5 ENSP00000360882.3 P20908-1
COL5A1ENST00000371820.4 linkc.4176+48A>G intron_variant Intron 53 of 65 2 ENSP00000360885.4 P20908-2H7BY82

Frequencies

GnomAD3 genomes
AF:
0.467
AC:
70824
AN:
151782
Hom.:
17296
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.622
Gnomad AMI
AF:
0.393
Gnomad AMR
AF:
0.394
Gnomad ASJ
AF:
0.365
Gnomad EAS
AF:
0.459
Gnomad SAS
AF:
0.338
Gnomad FIN
AF:
0.364
Gnomad MID
AF:
0.453
Gnomad NFE
AF:
0.420
Gnomad OTH
AF:
0.452
GnomAD2 exomes
AF:
0.416
AC:
102242
AN:
246056
AF XY:
0.409
show subpopulations
Gnomad AFR exome
AF:
0.631
Gnomad AMR exome
AF:
0.371
Gnomad ASJ exome
AF:
0.374
Gnomad EAS exome
AF:
0.478
Gnomad FIN exome
AF:
0.359
Gnomad NFE exome
AF:
0.419
Gnomad OTH exome
AF:
0.414
GnomAD4 exome
AF:
0.414
AC:
578778
AN:
1398780
Hom.:
121280
Cov.:
24
AF XY:
0.412
AC XY:
288278
AN XY:
699394
show subpopulations
African (AFR)
AF:
0.632
AC:
20540
AN:
32512
American (AMR)
AF:
0.375
AC:
16581
AN:
44196
Ashkenazi Jewish (ASJ)
AF:
0.369
AC:
9463
AN:
25656
East Asian (EAS)
AF:
0.451
AC:
17761
AN:
39340
South Asian (SAS)
AF:
0.352
AC:
29905
AN:
84924
European-Finnish (FIN)
AF:
0.360
AC:
19048
AN:
52872
Middle Eastern (MID)
AF:
0.441
AC:
2276
AN:
5164
European-Non Finnish (NFE)
AF:
0.416
AC:
438733
AN:
1055830
Other (OTH)
AF:
0.420
AC:
24471
AN:
58286
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
14192
28384
42576
56768
70960
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13228
26456
39684
52912
66140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.467
AC:
70902
AN:
151900
Hom.:
17322
Cov.:
33
AF XY:
0.460
AC XY:
34126
AN XY:
74260
show subpopulations
African (AFR)
AF:
0.622
AC:
25780
AN:
41414
American (AMR)
AF:
0.394
AC:
6017
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.365
AC:
1265
AN:
3464
East Asian (EAS)
AF:
0.459
AC:
2364
AN:
5150
South Asian (SAS)
AF:
0.338
AC:
1625
AN:
4804
European-Finnish (FIN)
AF:
0.364
AC:
3848
AN:
10568
Middle Eastern (MID)
AF:
0.456
AC:
134
AN:
294
European-Non Finnish (NFE)
AF:
0.421
AC:
28559
AN:
67908
Other (OTH)
AF:
0.450
AC:
952
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1929
3858
5787
7716
9645
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
638
1276
1914
2552
3190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.446
Hom.:
2869
Bravo
AF:
0.479
Asia WGS
AF:
0.401
AC:
1399
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibromuscular dysplasia, multifocal Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome, classic type, 1 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.54
DANN
Benign
0.37
PhyloP100
-1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10858283; hg19: chr9-137708973; COSMIC: COSV65666842; API